PRINTER'S NO. 1266
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE RESOLUTION
No.
220
Session of
2017
INTRODUCED BY McILHINNEY, DINNIMAN, FONTANA, MARTIN, BREWSTER,
GREENLEAF, FARNESE, SABATINA, SCAVELLO, BROWNE, EICHELBERGER,
AUMENT, WAGNER, HUGHES AND RAFFERTY, OCTOBER 17, 2017
INTRODUCED AND ADOPTED, OCTOBER 17, 2017
A RESOLUTION
Designating the month of October 2017 as "Lewy Body Dementia
Awareness Month" in Pennsylvania.
WHEREAS, Lewy body dementia (LBD) is a chronic, progressive
neurological disorder affecting thinking, movement, behavior and
sleep; and
WHEREAS, More than 1.4 million Americans are affected by LBD,
making it the second most common form of progressive dementia,
second only to Alzheimer's disease in prevalence; and
WHEREAS, The most common symptoms of LBD include problems
with memory and thinking, hallucinations, unpredictable changes
in concentration and attention, a sleep disorder causing people
to seemingly act out their dreams and Parkinson-like symptoms,
such as muscle rigidity or stiffness, a shuffling gait, tremors
or slowness of movement; and
WHEREAS, Unfamiliarity with LBD is widespread even among
health care professionals, making LBD the most commonly
misdiagnosed form of dementia; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
WHEREAS, Early and accurate diagnosis of LBD is essential
because some medications prescribed regularly for Alzheimer's or
Parkinson's disease can have serious negative effects on people
with LBD; and
WHEREAS, There is currently no cure, therapy or drug to slow
or halt the progression of LBD; therefore be it
RESOLVED, That the Senate designate the month of October 2017
as "Lewy Body Dementia Awareness Month"; and be it further
RESOLVED, That the Senate recognize the importance of
increasing public awareness of this disease and its early and
accurate diagnosis.
20170SR0220PN1266 - 2 -
1
2
3
4
5
6
7
8
9
10
11